We will support everyone's cancer genome research.
In recent years, our company has focused on cancer genome data analysis, supporting customers in various ways, from basic analyses such as SNV/indel mutation detection and annotation to advanced analyses including copy number variation analysis, structural variation analysis, mutational signature analysis, neoantigen discovery, and driver mutation exploration. We have also prepared analysis pipelines and standard operating procedures for the exploration of therapeutic targets and biomarkers through cancer genome analysis, and we provide support for clinical trial operations using NGS data for pharmaceutical companies. Please feel free to contact us if you have any requests. [Analysis and Development Content] ■ Basic Analysis ■ Environmental Setup and Research Investigation ■ Copy Number Variation Analysis, etc. *For more details, please download the PDF or feel free to contact us.
Inquire About This Product
basic information
【Other Analysis and Development Content】 ■Structural Variation Analysis ■Mutational Signature Analysis ■Neoantigen Discovery ■Driver Mutation Discovery ■Other NGS Analysis *For more details, please download the PDF or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please download the PDF or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company is developing its business based on three pillars: drug discovery and development based on a successful model, healthcare ICT business, and research support services. Leveraging our strengths as a group of experts in medicine, statistics, agriculture, and information science, we will expand our activities into various fields, including genome research of plants and animals, clinical research, as well as intellectual property evaluation and marketing assessment. Please feel free to contact us if you have any inquiries.